Clinical Trial: Treatment of Metastatic Cancer in Terminally Diagnosed Patients
Condition: Metastatic Cancer
Study Type: Expanded Access
Official Title: Not Provided
Brief Summary:
The objective is to provide terminally diagnosed patients with a last line of treatment while improving overall quality of life. Tempol can be added to any chemotherapy regimen to potentially reduce side effects and overcome chemoresistance.
Read more